The role of idecabtagene vicleucel in patients with heavily pretreated refractory multiple myeloma THER ADV HEMATOL
Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes J CLIN ONCOL
CART19-BE-01: A Multicenter Trial of ARI-0001 Cell Therapy in Patients with CD19+Relapsed/Refractory Malignancies MOL THER
Discovery of novel DNA methylation biomarkers for non-invasive sporadic breast cancer detection in the Latino population MOL ONCOL
Epigenetic loss of m<SUP>1</SUP>A RNA demethylase ALKBH3 in Hodgkin lymphoma targets collagen, conferring poor clinical outcome BLOOD
NK cells enhance CAR-T cell antitumor efficacy by enhancing immune/tumor cells cluster formation and improving CAR-T cell fitness J IMMUNOTHER CANCER